Cargando…

Rational approach to drug discovery for human schistosomiasis

Human schistosomiasis is a debilitating, life-threatening disease affecting more than 229 million people in as many as 78 countries. There is only one drug of choice effective against all three major species of Schistosoma, praziquantel (PZQ). However, as with many monotherapies, evidence for resist...

Descripción completa

Detalles Bibliográficos
Autores principales:	LoVerde, Philip T., Alwan, Sevan N., Taylor, Alexander B., Rhodes, Jayce, Chevalier, Frédéric D., Anderson, Timothy JC., McHardy, Stanton F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Regular article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193065/ https://www.ncbi.nlm.nih.gov/pubmed/34111649 http://dx.doi.org/10.1016/j.ijpddr.2021.05.002

Ejemplares similares

Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147]
por: LoVerde, Philip T., et al.
Publicado: (2022)

Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis
por: Alwan, Sevan N., et al.
Publicado: (2023)

Addressing the oxamniquine in vitro-in vivo paradox to facilitate a new generation of anti-schistosome treatments
por: Toth, Katalin, et al.
Publicado: (2023)

Schistosome Sulfotransferases: Mode of Action, Expression and Localization
por: Guzman, Meghan A., et al.
Publicado: (2022)

An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans
por: Guzman, Meghan A., et al.
Publicado: (2020)

Efficient linkage mapping using exome capture and extreme QTL in schistosome parasites
por: Chevalier, Frédéric D, et al.
Publicado: (2014)

Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?
por: Rugel, Anastasia R., et al.
Publicado: (2020)

Genomic linkage map of the human blood fluke Schistosoma mansoni
por: Criscione, Charles D, et al.
Publicado: (2009)

Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model
por: Carvalho-Queiroz, Claudia, et al.
Publicado: (2015)

Identification and evolution of nuclear receptors in Platyhelminths
por: Wu, Wenjie, et al.
Publicado: (2021)

Updated knowledge and a proposed nomenclature for nuclear receptors with two DNA binding domains (2DBD-NRs)
por: Wu, Wenjie, et al.
Publicado: (2023)

Thyroid hormone receptor orthologues from invertebrate species with emphasis on Schistosoma mansoni
por: Wu, Wenjie, et al.
Publicado: (2007)

Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022
por: Caldwell, Nicola, et al.
Publicado: (2023)

Recent Advances in the Discovery of Haem-Targeting Drugs for Malaria and Schistosomiasis
por: de Villiers, Katherine A., et al.
Publicado: (2009)

Schistosomiasis vaccine discovery using immunomics
por: Driguez, Patrick, et al.
Publicado: (2010)

Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty
por: Savioli, Lorenzo, et al.
Publicado: (2017)

Evolution of a novel subfamily of nuclear receptors with members that each contain two DNA binding domains
por: Wu, Wenjie, et al.
Publicado: (2007)

Atypical Presentation of Acute Appendicitis with Schistosomiasis
por: Alsayegh, Hassan A, et al.
Publicado: (2021)

Schistosoma mansoni TGF-β Receptor II: Role in Host Ligand-Induced Regulation of a Schistosome Target Gene
por: Osman, Ahmed, et al.
Publicado: (2006)

Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence
por: Moreira-Filho, José T., et al.
Publicado: (2021)

Discovery of a Hidden Schistosomiasis Endemic in the Salamat Region of Chad, Africa
por: Visclosky, Timothy, et al.
Publicado: (2022)

Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery
por: Maccesi, Martina, et al.
Publicado: (2019)

Structural and Functional Characterization of the Enantiomers of the Antischistosomal Drug Oxamniquine
por: Taylor, Alexander B., et al.
Publicado: (2015)

Rational Inference of Beliefs and Desires From Emotional Expressions
por: Wu, Yang, et al.
Publicado: (2017)

Emerging Computational Methods for the Rational Discovery of Allosteric Drugs
por: Wagner, Jeffrey R., et al.
Publicado: (2016)

Covalent inhibitors: a rational approach to drug discovery
por: Sutanto, Fandi, et al.
Publicado: (2020)

Strong Ties and Weak Ties Rationality: Theory and Scale Development
por: Sundararajan, Louise, et al.
Publicado: (2021)

Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis
por: Pearson, Mark S., et al.
Publicado: (2021)

Macroeconomic dynamics under bounded rationality: on the impact of consumers’ forecast heuristics
por: Jang, Tae-Seok, et al.
Publicado: (2022)

Tamoxifen blocks retrograde trafficking of Shiga toxin 1 and 2 and protects against lethal toxicosis
por: Selyunin, Andrey S, et al.
Publicado: (2019)

Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis
por: Pereira Moreira, Bernardo, et al.
Publicado: (2022)

Improving the catalytic activity of a detergent‐compatible serine protease by rational design
por: Wang, Xiao, et al.
Publicado: (2023)

Probabilistic variable-length segmentation of protein sequences for discriminative motif discovery (DiMotif) and sequence embedding (ProtVecX)
por: Asgari, Ehsaneddin, et al.
Publicado: (2019)

Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis
por: Alcântara, Laura M., et al.
Publicado: (2018)

Trichuris muris egg-hatching assay for anthelminthic drug discovery and characterization
por: Schärer, Anastasia, et al.
Publicado: (2023)

Materials discovery at BESSY
por: Schwarzkopf, Olaf, et al.
Publicado: (2023)

Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains
por: Silva, Ana Catarina Cristovão, et al.
Publicado: (2019)

Rational design of Striga hermonthica-specific seed germination inhibitors
por: Zarban, Randa A, et al.
Publicado: (2021)

Risk assessment and rationalization of health resource allocation: Lessons from the Brazilian COVID-19 cohort in 2020
por: Cattani, Vitória Berg, et al.
Publicado: (2022)

A multi-dimensional, time-lapse, high content screening platform applied to schistosomiasis drug discovery
por: Chen, Steven, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ljoqf952j5c80kf5kn9uggbm0j